Results 121 to 130 of about 26,257 (175)

Nationwide Analysis of In-Hospital Mortality in Patients with Encephalitis-Related Diagnoses in Ecuador. [PDF]

Diseases
Montes-Escobar K, Ramirez-Veloz CE, Pérez-Pirela MC, Giler RLS, Zambrano Pico FV, Reyes-Mena FS, Torres J, Cano Y, Siteneski A.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Human T lymphotropic virus‐1 infection

Australasian Journal of Dermatology, 1996
SUMMARYHuman T lymphotropic virus‐1 (HTLV‐1) is a retrovirus which infects T lymphocytes (CD4+) to cause adult T cell leukaemia/lymphoma (ATL), tropical spastic paraparesis and several other HTLV‐1 associated disorders. ATL has been reported worldwide but areas of high incidence include Japan (particularly the south‐west), Central and South America ...
T, Kanzaki, M, Setoyama, Y, Katahira
openaire   +2 more sources

Human T-lymphotropic virus type 1 infection

Best Practice & Research Clinical Haematology, 2000
Human T-cell lymphotropic virus type-1 (HTLV-1) is aetiologically associated with adult T-cell leukaemia/lymphoma (ATL). HTLV-1 infection can also lead to various non-malignant diseases, for example, HTLV-1 associated myelopathy/tropical spastic paraparesis and HTLV-1 uveitis. HTLV-1 is endemic in southern Japan and the Caribbean.
K, Tsukasaki, P, Koeffler, M, Tomonaga
openaire   +2 more sources

Human T-lymphotropic virus 1 neurologic disease

Current Treatment Options in Neurology, 2008
Human T-lymphotrophic virus 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a disabling myelopathy, but clinical trials of specific drugs to treat it are lacking. There are many reasons for the absence of specific therapeutic studies, including difficulty in enrolling patients, inadequate measurement tools to evaluate ...
Abelardo, Araújo, Marco Antonio, Lima, Marcus Tulius T, Silva   +2 more
openaire   +2 more sources

Infection of defective human T-lymphotropic virus type 1

Human Cell, 2017
In a previous study, we reported that an identical defective provirus had integrated into multiple sites of the genome of a representative human T-lymphotropic virus type 1 (HTLV-1) cell line, MT-2. A possible explanation for this may be the repeated infection of this defective provirus to a cell.
Yuuki, Hashikura, Kazumi, Umeki, Kunihiko, Umekita, Hajime, Nomura, Akiteru, Yamada, Ikuo, Yamamoto, Hiroo, Hasegawa, Katsunori, Yanagihara, Akihiko, Okayama   +8 more
openaire   +2 more sources

Human T-lymphotropic virus type 1 infection and disease in Spain

AIDS, 2017
: Human T-lymphotropic virus type 1 (HTLV-1) infection is a neglected disease despite roughly 15 million people are chronically infected worldwide. Lifelong less than 10% of carriers develop life-threatening diseases, mostly a subacute myelopathy known as tropical spastic paraparesis (TSP) and a lymphoproliferative disorder named adult T-cell leukemia (
Mendoza, Carmen de, Caballero, Estrella, Aguilera, Antonio, Requena, Silvia, Ortiz de Lejarazu, Raúl, Pirón, María, González, Rocío, Jiménez, Ana, Roc, Lourdes, Treviño, Ana, Benito, Rafael, Fernández-Alonso, Miriam, Aguinaga, Aitziber, Rodríguez, Carmen, García-Costa, Juan, Blanco, Lidia, Ramos, José M., Calderón, Enrique J., Eirós, José M., Sauleda, Silvia, Barreiro, Pablo, Soriano, Vicente   +21 more
openaire   +3 more sources

The epidemiology of myelopathy associated with human T-lymphotropic virus 1

Transactions of the Royal Society of Tropical Medicine and Hygiene, 1993
A progressive spastic myelopathy is one of the principal manifestations of the human T cell lymphotropic virus type 1. Recent research is reviewed on the geography and epidemiology of this specific form of tropical spastic paraparesis. First recognized in the Caribbean, Colombia and Japan, it is now also confirmed as a major neurological problem in ...
openaire   +2 more sources